医学
卡培他滨
肿瘤科
化疗
乳腺癌
佐剂
内科学
辅助化疗
乳腺癌
癌症
乳房切除术
氟尿嘧啶
结直肠癌
作者
Norikazu Masuda,Soo-Jung Lee,Shoichiro Ohtani,Young‐Hyuck Im,Eun Sook Lee,Isao Yokota,Katsumasa Kuroi,Seock‐Ah Im,Byeong‐Woo Park,Sung‐Bae Kim,Yasuhiro Yanagita,Shinji Ohno,Shintaro Takao,Kenjiro Aogi,Hiroji Iwata,Joon Jeong,Aeree Kim,Kyong Hwa Park,Hironobu Sasano,Yasuo Ohashi,Masakazu Toi
标识
DOI:10.1056/nejmoa1612645
摘要
Patients who have residual invasive carcinoma after the receipt of neoadjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)–negative breast cancer have poor prognoses. The benefit of adjuvant chemotherapy in these patients remains unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI